ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,587Medicare Part D Prescriptions Filled, Including Refills

Rank: 16 out of 2888

$1.76M Total Retail Price of All Prescriptions

Rank: 42 out of 2888

854 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 854 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

26% of this provider’s 854 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 30,051 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
FUROSEMIDE 1,361 1,277 1 6
LEVOTHYROXINE SODIUM 1,207 1,129 2 1
SIMVASTATIN 948 843 3 2
HYDROCODONE-ACETAMINOPHEN 902 711 S3 4 4
WARFARIN SODIUM 855 773 5 22
OMEPRAZOLE 813 742 6 7
LISINOPRIL 808 723 7 3
POTASSIUM CHLORIDE 804 741 8 14
DONEPEZIL HCL 773 772 9 26
METOPROLOL TARTRATE 748 655 10 10
AMLODIPINE BESYLATE 724 646 11 5
NAMENDA 654 641 12 34
GABAPENTIN 625 495 13 13
CARVEDILOL 516 471 14 21
MIRTAZAPINE 475 432 15 54
CYMBALTA 448 407 16 44
TRAZODONE HCL 436 354 17 43
SERTRALINE HCL 423 396 18 27
CITALOPRAM HBR 417 356 19 24
ESCITALOPRAM OXALATE 406 375 20 62
QUETIAPINE FUMARATE 373 331 21 66
METFORMIN HCL 350 294 22 8
TRAMADOL HCL 338 300 23 16
METOPROLOL SUCCINATE 327 301 24 11
NOVOLIN R 315 273 25 109
KLOR-CON M20 294 283 26 90
RANITIDINE HCL 291 268 27 56
TAMSULOSIN HCL 290 260 28 29
PANTOPRAZOLE SODIUM 284 267 29 33
LIDODERM 280 256 30 105
IPRATROPIUM-ALBUTEROL 264 248 31 150
RISPERIDONE 238 198 32 72
ZOLPIDEM TARTRATE 237 174 33 17
CLOPIDOGREL 232 207 34 30
DIGOXIN 224 211 35 55
PRAVASTATIN SODIUM 223 199 36 12
LANTUS 216 179 37 45
MEGESTROL ACETATE 209 203 R 38 140
LEVOFLOXACIN 206 183 39 57
BACLOFEN 196 108 40 121
CLONIDINE HCL 194 186 41 39
ALENDRONATE SODIUM 179 163 42 23
HYDRALAZINE HCL 179 157 42 59
ALBUTEROL SULFATE 178 162 44 134
ATORVASTATIN CALCIUM 175 167 45 9
CIPROFLOXACIN HCL 174 155 46 47
MELOXICAM 172 170 47 31
ISOSORBIDE MONONITRATE ER 167 156 48 51
FAMOTIDINE 166 135 49 75
LEVETIRACETAM 162 125 50 103
PLAVIX 156 146 51 40
LYRICA 156 138 51 69
ATENOLOL 155 150 53 25
PROMETHAZINE HCL 152 123 R 54 96
SEROQUEL 150 137 55 143
EXELON 149 148 56 106
NOVOLOG 141 138 57 114
OLANZAPINE 141 132 57 137
HYDROCHLOROTHIAZIDE 138 115 59 15
GLIPIZIDE 136 136 60 50
NEXIUM 135 106 61 19
PREDNISONE 135 131 61 42
NITROFURANTOIN MONO-MACRO 132 121 63 162
CARBIDOPA-LEVODOPA 123 123 64 113
AMIODARONE HCL 123 122 64 167
OXYBUTYNIN CHLORIDE ER 121 96 66 132
DIVALPROEX SODIUM 117 92 67 100
RAMIPRIL 116 93 68 73
DIOVAN 116 115 68 35
LEXAPRO 116 107 68 198
FLUTICASONE PROPIONATE 112 97 71 32
VENLAFAXINE HCL 107 100 72 246
KLOR-CON M10 105 101 73 118
VESICARE 104 97 74 154
LOSARTAN POTASSIUM 103 103 75 18
VENLAFAXINE HCL ER 101 94 76 120
TRAVATAN Z 101 101 76 239
SPIRONOLACTONE 100 98 78 70
PAROXETINE HCL 100 99 78 84
BUSPIRONE HCL 100 81 78 148
CEFUROXIME 100 94 78 130
POLYETHYLENE GLYCOL 3350 100 94 78 93
NIFEDIPINE ER 99 88 83 76
ADVAIR DISKUS 98 97 84 60
ROPINIROLE HCL 97 94 85 115
SULFAMETHOXAZOLE-TRIMETHOPRIM 96 85 86 88
ALLOPURINOL 95 95 87 37
NYSTATIN 93 87 88 178
PHENYTOIN SODIUM EXTENDED 91 64 89 128
TRICOR 91 90 89 91
CELEBREX 88 85 91 89
ENOXAPARIN SODIUM 87 83 92 307
METOCLOPRAMIDE HCL 87 69 92 116
MUPIROCIN 85 76 94 184
LATANOPROST 83 74 95 197
ZETIA 77 77 96 81
SUCRALFATE 76 62 97 187
DOXAZOSIN MESYLATE 76 65 97 94
DILTIAZEM HCL 75 72 99 236
DOXYCYCLINE HYCLATE 74 62 100 123
ACETAZOLAMIDE 74 66 100 511
SPIRIVA 73 60 102 79
CRESTOR 73 73 102 20
HUMULIN R 69 57 104 233
LOVAZA 68 66 105 97
RIVASTIGMINE 68 58 105 335
DETROL LA 67 54 107 192
OXYBUTYNIN CHLORIDE 67 49 107 124
ABILIFY 66 65 109 172
SANTYL 66 62 109 210
CEPHALEXIN 65 64 111 119
AMOX TR-POTASSIUM CLAVULANATE 64 53 112 112
NITROFURANTOIN 63 61 113 241
SODIUM CHLORIDE 59 50 114 371
DIVALPROEX SODIUM ER 58 45 115 185
COMBIGAN 58 58 115 457
GLYBURIDE 56 56 R 117 58
RENVELA 56 50 117 279
FINASTERIDE 56 55 117 102
LACTULOSE 56 50 117 111
IPRATROPIUM BROMIDE 55 49 121 188
GENTAMICIN SULFATE 52 44 122 320
FLUCONAZOLE 51 45 123 199
PROPRANOLOL HCL 51 46 123 164
JANTOVEN 51 51 123 163
AZITHROMYCIN 51 46 123 38
SINGULAIR 50 50 127 85
AMOXICILLIN 50 37 127 117
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 19, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.